Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR, 97201, USA.
Beckman Coulter Life Sciences, Loveland, CO, 80538, USA.
Chemistry. 2021 Feb 15;27(10):3229-3237. doi: 10.1002/chem.202003523. Epub 2020 Dec 15.
X-ray radiation is commonly employed in clinical practice for diagnostic and therapeutic applications. Over the past decade, developments in nanotechnology have led to the use of high-Z elements as the basis for innovative new treatment platforms that enhance the clinical efficacy of X-ray radiation. Nanoscale metal-frameworks (nMOFs) are coordination networks containing organic ligands that have attracted attention as therapeutic platforms in oncology and other areas of medicine. In cancer therapy, X-ray activated, high-Z nMOFs have demonstrated potential as radiosensitizers that increase local radiation dose deposition and generation of reactive oxygen species (ROS). This minireview summarizes current research on high-Z nMOFs in cancer theranostics and discusses factors that may influence future clinical application.
X 射线辐射在临床诊断和治疗应用中被广泛使用。在过去的十年中,纳米技术的发展导致了高 Z 元素的应用,这些元素作为创新的新型治疗平台的基础,提高了 X 射线辐射的临床疗效。纳米尺度金属框架(nMOFs)是包含有机配体的配位网络,它们作为治疗平台在肿瘤学和医学的其他领域引起了关注。在癌症治疗中,X 射线激活的高 Z nMOFs 已被证明具有作为放射增敏剂的潜力,可增加局部辐射剂量沉积并产生活性氧(ROS)。本综述总结了当前癌症治疗中的高 Z nMOFs 的研究,并讨论了可能影响未来临床应用的因素。